EDN1 and neoplasm: In serous ovarian cancer (SOC), ETAR activated by ET-1 orchestrates various tumor-associated processes such as proliferation, apoptosis, epithelial-to-mesenchymal transition, and invasion, thereby supporting metastasis and resistance to therapeutics [4].